Structure-Based Drug Design, Molecular Dynamics and ADME/Tox to Investigate Protein Kinase Anti-Cancer Agents

Publisher： Bentham Science Publishers

E-ISSN： 1875-6646|13|3|213-222

ISSN： 1573-4072

Source： Current Bioactive Compounds, Vol.13, Iss.3, 2017-07, pp. : 213-222

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Advances in the Structure-Based and Ligand-Based Design of IKK&bgr; Inhibitors as Anti-inflammation and Anti-cancer Agents

By  

Current Medicinal Chemistry, Vol. 21, Iss. 34, 2014-11 ,pp. : 3893-3917

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Protein Multiple Conformations: A Structure-Based Strategy for Kinase Drug Design

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 14, 2007-07 ,pp. : 1394-1407

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-Based Design of Novel Anticancer Agents

By  

Current Cancer Drug Targets, Vol. 1, Iss. 1, 2001-05 ,pp. : 59-71

Bentham Science Publishers

Access to resources Recommend Favorite

Computational ADME/Tox Modeling: Aiding Understanding and Enhancing Decision Making in Drug Design

By  

Current Computer - Aided Drug Design, Vol. 1, Iss. 4, 2005-10 ,pp. : 325-345

Bentham Science Publishers

Access to resources Recommend Favorite

Accommodating Protein Flexibility for Structure-Based Drug Design

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 2, 2011-01 ,pp. : 171-178

Bentham Science Publishers

Access to resources Recommend Favorite